IDENTIFICATION OF HYPERLIPIDEMIA RISK FACTORS AND QUANTIFICATION OF TCM CONSTITUTIONAL CONTRIBUTIONS: A MULTIDIMENSIONAL METRIC FRAMEWORK
Keywords:
Hyperlipidemia, LASSO feature selection, TCM constitution risk, Odds ratio measurementAbstract
Against the backdrop of rising hyperlipidemia prevalence and limited management resources, the precise identification of key risk factors in high-risk populations is of great significance for improving public health. Based on clinical data from 1,000 middle-aged and elderly patients, this study constructed a composite measurement framework combining linear contraction and nonlinear evaluation, aiming to systematically identify core risk indicators for hyperlipidemia and assess the marginal contribution of Traditional Chinese Medicine (TCM) constitutions. The study first employed a LASSO regression model with L1 regularization to perform embedded screening of the initial high-dimensional features, effectively overcoming the interference of multicollinearity among lipid indicators. Subsequently, supplementary validation was conducted by integrating importance rankings from random forests, ultimately identifying eight core early warning indicators, including total cholesterol (TC), triglycerides (TG), BMI, and the total score of the physical activity questionnaire. These indicators demonstrated strong clinical predictive utility. Regarding the quantification of constitutional risk contributions, to address statistical biases caused by mixed constitutions, the study introduced a regularized logistic regression model with signed constraints for corrective estimation. Empirical results indicate that the Phlegm-Dampness constitution is the susceptibility factor with the highest risk of disease onset and the greatest statistical significance, with an odds ratio of 1.15, while the Harmonious constitution exhibits a clear health-protective effect. This study provides empirical evidence for the development of an early warning system for chronic diseases that deeply integrates traditional Chinese medicine (TCM) and Western medicine.References
[1] Li X, Hak E, Bos JHJ, et al. Long-Term Adherence and Drug Utilisation Patterns Among New Users of Anti-Hyperlipidemic Monotherapy: Development of a Risk Prediction Model. Journal of Evaluation in Clinical Practice, 2026, 32(1): e70380.
[2] Qu D, Xia Y, Wang G, et al. Parabacteroides distasonis AR1098 mediates anti-hyperlipidemic effects via coordinated bile acid excretion and lipogenesis suppression in the gut-liver axis. Food Bioscience, 2026, 75: 108095.
[3] Abdulai K, Alhassan RA, Anane I, et al. High dyslipidemia in people living with HIV in ghana: a cross-sectional analysis of prevalence and associated factors. AIDS Research and Therapy, 2025, 22(1): 120.
[4] Neuhauser H, Sarganas G, Du Y, et al. Improving European Health Interview Survey (EHIS) data on high blood pressure and high cholesterol. European Journal of Public Health, 2025, 35(Supplement_4).
[5] Nobelos TP, Rekka AE. Pluripotent Cinnamic Acid and Valproic Acid Hybrid Molecules Designed as Strong Anti-inflammatory and Anti-hyperlipidemic Compounds. Medicinal Chemistry (Shariqah (United Arab Emirates)), 2025.
[6] Su J, Li P, Tang X, et al. Ultrasonic extraction of polyphenols from roots of Ilex asprella: Structural characterization, antioxidant, antimicrobial, anti-inflammatory, and anti-hyperlipidemic activities. Ultrasonics Sonochemistry, 2025, 120: 107462.
[7] Amghar S, Bärnighausen T, Jani A. Missed opportunities for health promotion and disease prevention: lifestyle interventions in primary care for individuals with hypertension, hyperlipidemia, obesity and type 2 diabetes. Panminerva Medica, 2025, 67(2): 108-120.
[8] Choi K. Correlation Between Hyperlipidemia-Related Diseases and Thorax/Thigh Circumference Ratio Along with Body Condition Score in Dogs Focusing on Molecular Mechanism: A Pilot Study and Literature Review. Life, 2024, 14(11): 1441.
[9] Zhou X, Wang X, Ou T, et al. Association between family economic situation and serum PFAS concentration in American adults with hypertension and hyperlipemia. Scientific Reports, 2024, 14(1): 20799.
[10] Arshed M, Umer FM, Kiran M, et al. Prevalence and associated factors of non-adherence to antihyperlipidemic medication: a nationwide cross sectional survey in Pakistan. Scientific Reports, 2024, 14(1): 20613.